Our R&D Vision

In order to become a global leader in pharma with competitive advantages in intensive care unit to contribute to a healthy society

Our goal is to scale up our investments in R&D to create a global center by building a robust core research to generate funds that can fast-track Polifarma’s pursuit of tomorrow’s innovative therapies invention.

Our R&D center supports the philosophy of Polifarma by providing niche services to large and diverse clientele reflecting the progress made in various R&D programs. In this aspect we are combining our knowledge and in-house expertise in the production of parenteral solutions to become a pioneer in innovative medicine development activities.







Our R&D Goals

As POLİFARMA İLAÇ, our R&D goals are as follows:

  • Ensure sustainable growth and develop new products along the pharmaceutical industry in Turkey,
  • Focus on developing viable medical solutions that contribute to the improvement of the living quality of each patient,
  • Make a difference and add value to our products by implementing innovations that meet basic medical needs of the society,
  • Generate solutions and add value to health by identifying unmet medical needs in Turkey and globally,
  • Become a global competitor in accordance with the dynamics and requirements of the global growth markets and develop products with high added value,
  • Synthesize the molecule of the raw material of a product that will be used in Turkey and in the world for the first time,
  • Protect our intellectual property rights through our patent registrations.
  • Engage in novelty and follow global market growth to enhance new businesses involving industry, universities and government.
  • Leverage in house capabilities to build a robust platform through the evolution of existing products as well as novel product development
  • Establish a competitive pipeline and quickly deliver unique novel molecules worldwide.
  • Contribute continuously to global sustainability to make better society of clean environment




R&D Technical Characteristics
Laboratory Information

We conduct our scientific activities by using the state-of-the-art devices.

  • HPLC & UPLC
  • HPLC-MS
  • GC
  • GC-MS
  • ICP MS
  • Atomic Absorption
  • Zeta Sizer
  • Particle Size Measurement
  • FT-IR
  • Viscometer
  • Cryostat Microscope
  • Karl Fisher
  • Potentiometer
  • Freeze Drying Machine
  • UV Spectrometer
  • Dissolution
  • High Pressure Homogenizer
  • Ready-to-Use Syringe Unit



Awards and Achievements

Our POL R&D team:

  • Successfully completed over 50 TÜBİTAK projects,
  • Has over 50 patents registered by the European Patent Office,
  • Developed over 700 generic medicines based on its over 20-year experience in R&D,
  • Presented over 500 medicines to the market in Turkey and over 40 medicines in the European Union countries and in United States,
  • Established a biotech hub in collaboration with top universities and government.

Our R&D Vision

In order to become a global leader in pharma with competitive advantages in intensive care unit to contribute to a healthy society

Our goal is to scale up our investments in R&D to create a global center by building a robust core research to generate funds that can fast-track Polifarma’s pursuit of tomorrow’s innovative therapies invention.

Our R&D center supports the philosophy of Polifarma by providing niche services to large and diverse clientele reflecting the progress made in various R&D programs. In this aspect we are combining our knowledge and in-house expertise in the production of parenteral solutions to become a pioneer in innovative medicine development activities.







Our R&D Goals

As POLİFARMA İLAÇ, our R&D goals are as follows:

  • Ensure sustainable growth and develop new products along the pharmaceutical industry in Turkey,
  • Focus on developing viable medical solutions that contribute to the improvement of the living quality of each patient,
  • Make a difference and add value to our products by implementing innovations that meet basic medical needs of the society,
  • Generate solutions and add value to health by identifying unmet medical needs in Turkey and globally,
  • Become a global competitor in accordance with the dynamics and requirements of the global growth markets and develop products with high added value,
  • Synthesize the molecule of the raw material of a product that will be used in Turkey and in the world for the first time,
  • Protect our intellectual property rights through our patent registrations.
  • Engage in novelty and follow global market growth to enhance new businesses involving industry, universities and government.
  • Leverage in house capabilities to build a robust platform through the evolution of existing products as well as novel product development
  • Establish a competitive pipeline and quickly deliver unique novel molecules worldwide.
  • Contribute continuously to global sustainability to make better society of clean environment




R&D Technical Characteristics
Laboratory Information

We conduct our scientific activities by using the state-of-the-art devices.

  • HPLC & UPLC
  • HPLC-MS
  • GC
  • GC-MS
  • ICP MS
  • Atomic Absorption
  • Zeta Sizer
  • Particle Size Measurement
  • FT-IR
  • Viscometer
  • Cryostat Microscope
  • Karl Fisher
  • Potentiometer
  • Freeze Drying Machine
  • UV Spectrometer
  • Dissolution
  • High Pressure Homogenizer
  • Ready-to-Use Syringe Unit



Awards and Achievements

Our POL R&D team:

  • Successfully completed over 50 TÜBİTAK projects,
  • Has over 50 patents registered by the European Patent Office,
  • Developed over 700 generic medicines based on its over 20-year experience in R&D,
  • Presented over 500 medicines to the market in Turkey and over 40 medicines in the European Union countries and in United States,
  • Established a biotech hub in collaboration with top universities and government.